The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The ...

Figure 1: Antibody design to improve homogeneity ... Thus, decreasing costs is an important part of drug development. The IgG-based biotherapeutic agents that have been approved in the past ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

The European Commission (EC) has approved catumaxomab, making it the only approved drug therapy for malignant ascites (MA) for patients living with this debilitating condition across Europe.

India's Contract Development and Manufacturing Organization (CDMO) market is poised for exponential growth, expected to ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

Astellas has invested heavily in novel technologies that are not necessarily the most successful or popular in the industry.

The Scottish Medicines Consortium announced lecanemab would not be made available on the NHS, following a similar decision ...

Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...